转移性前列腺癌治疗的进展
Georges Gebrael1, Gliceida Galarza Fortuna1, Nicolas Sayegh1
1Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Trends in cancer
|July 13, 2023
概括
转移性前列腺癌 (mPCa) 治疗的最新进展包括新的三重疗法和针对性药物,如177Lu-PSMA-617. 导航这些选项需要仔细考虑临床试验数据,以获得最佳的患者结果.
科学领域:
- 在瘤学瘤学.
- 医学治疗学 医学治疗学
背景情况:
- 转移性前列腺癌 (mPCa) 治疗已经迅速发展.
- 近年来,有大量的治疗批准和正在进行的研究.
研究的目的:
- 审查过去两年的mPCa临床试验里程碑.
- 讨论最佳治疗选择和测序策略.
- 为未来的治疗方向提供洞察力.
主要方法:
- 对最近发表的和正在进行的mPCa.里程碑式临床试验的审查.
- 对新的治疗批准和研究药物的分析.
- 基于试验数据进行治疗选择和测序的讨论.
主要成果:
- 最近批准的药物包括对割敏感的mPCa的三重疗法 (ADT,dcetaxel,ARPI).
- 对抗割的mPCa的批准包括177Lu-PSMA-617和PARPi/ARPI组合.
- 许多药物处于后期试验阶段,扩大治疗选择.
结论:
- 在mPCa中不断扩大的治疗场景在治疗选择和测序方面带来了挑战.
- 最近临床试验的证据对于指导最佳治疗策略至关重要.
- 未来的方向包括对新型药物和组合的持续研究和开发.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


